Immunochemical quantification of free immunoglobulin light chains from an analytical perspective

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 5, 2006, Pages 522-532

  Nakano, Takanari ^a   Miyazaki, Shuichi ^b   Takahashi, Hidenori ^c   Matsumori, Akira ^d   Maruyama, Taro ^e   Komoda, Tsugikazu ^a   Nagata, Atsuo ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b YAMASA CORPORATION   (Japan)

^c ASAHI GENERAL HOSPITAL   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SAITAMA SOCIAL INSURANCE HOSPITAL   (Japan)

Author keywords

Antibody; Bence Jones protein; Free immunoglobulin light chain; Immunoassay; Standardization

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN LIGHT CHAIN;

ACCURACY; HUMAN; IMMUNOCHEMISTRY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MONOCLONAL IMMUNOGLOBULINEMIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; URINE LEVEL;

ANTIBODIES, MONOCLONAL; BENCE JONES PROTEIN; CALIBRATION; CHEMISTRY, CLINICAL; HUMANS; IMMUNOASSAY; IMMUNOCHEMISTRY; IMMUNOGLOBULIN LIGHT CHAINS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY;

EID: 33646700777     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.118     Document Type: Review

References (73)

1. Bence Jones H. Papers on chemical pathology: lecture III. Lancet 1847;ii:88-92.
2. Edelman GM, Gally JA. The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins. J Exp Med 1962;116:207-27.
3. Merlini G, Aguzzi F, Whicher J. Monoclonal gammopathies. J Int Fed Clin Chem 1997;9:171-6.
4. Graziani M, Merlini G, Petrini C. Guidelines for the analysis of Bence Jones protein. Clin Chem Lab Med 2003;41:338-46.
5. Marshall T, Williams KM. Electrophoretic analysis of Bence Jones proteinuria. Electrophoresis 1999;20:1307-24.
6. Levinson SS, Keren DF. Free light chains of immunoglobulins: clinical laboratory analysis. Clin Chem 1994;40:1869-78.
7. Brigden ML, Neal ED, McNeely MD, Hoag GN. The optimum urine collections for the detection and monitoring of Bence Jones proteinuria. Am J Clin Pathol 1990;93:689-93.
8. Monos DS, Bina M, Kahn SN. Evaluation and optimization of variables in immunofixation electrophoresis for the detection of IgG paraproteins. Clin Biochem 1989;22:369-71.
9. Tan M, Epstein WV. A direct immunologic assay of human sera for Bence Jones proteins (L-chains). J Lab Clin Med 1965;66:344-56.
10. Sölling K, Nielsen JL, Sölling J, Ellegaard J. Free light chains of immunoglobulins in serum from patients with leukaemias and multiple myeloma. Scand J Haematol 1982;28:309-18.
11. McLaughlin P, Alexanian R. Myeloma protein kinetics following chemotherapy. Blood 1982;60:851-5.
12. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-80.
13. Bradwell AR, Carr-Smith H, Mead GP, Drayson M. Serum free light chain immunoassays and their clinical application. Clin Appl Immunol Rev 2002;3:17-33.
14. Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA. Diagnostic performance of quantitative κ and λ free light chain assays in clinical practice. Clin Chem 2005;51:878-81.
15. Gertz MA, Commenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN. Definition of organ involvement and treatment response in primary systemic amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. In: Gateau G, Kyle RA, Skinner M, editors. Amyloid and amyloidosis. Boca Raton, FL: CRC Press, 2004:151-3.
16. Tate JR, Gill D, Cobcroft R, Hickman PE. Practical considerations for the measurement of free light chains in serum. Clin Chem 2003;49:1252-7.
17. Nakano T, Nagata A. ELISAs for free human immunoglobulin light chains in serum: improvement of assay specificity by using two specific antibodies in a sandwich detection method. J Immunol Methods 2004;293:183-9.
18. Sölling K. Free light chains of immunoglobulins. Scand J Clin Lab Invest Suppl 1981;157:1-83.
19. Bradwell AR. Serum free light chain measurements move to center stage. Clin Chem 2005;51:805-7.
20. Dammacco F, Waldenström J. Serum and urine light chain levels in benign monoclonal gammapathies, multiple myeloma and Waldenström's macroglobulinaemia. Clin Exp Immunol 1968;3:911-21.
21. Mann D, Granger H, Fahey JL. Use of insoluble antibody for quantitative determination of small amounts of immunoglobulin. J Immunol 1969;102:618-24.
22. Peterson PA, Berggård I. Urinary immunoglobulin components in normal, tubular, and glomerular proteinuria: quantities and characteristics of free light chains, IgG, IgA, and Fc-gamma fragment. Eur J Clin Invest 1971;1:255-64.
23. Abraham GN, Waterhouse C. Evidence for defective immunoglobulin metabolism in severe renal insufficiency. Am J Med Sci 1974;268:227-33.
24. Sölling K. Free light chains of immunoglobulins in normal serum and urine determined by radioimmunoassay. Scand J Clin Lab Invest 1975;35:407-12.
25. Hemmingsen L, Skaarup P. Urinary excretion of ten plasma proteins in patients with febrile diseases. Acta Med Scand 1977;201:359-64.
26. Cole PW, Durie BG, Salmon SE. Immunoquantitation of free light chain immunoglobulins: applications in multiple myeloma. J Immunol Methods 1978;19:341-9.
27. Robinson EL, Gowland E, Ward ID, Scarffe JH. Radioimmunoassay of free light chains of immunoglobulins in urine. Clin Chem 1982;28:2254-8.
28. k epitopes not available on whole immunoglobulins. Clin Exp Immunol 1983;52:234-40.
29. McLeod BC, Viernes AL, Sassetti RJ. Serum-free light chain analysis by crossed immunoelectrophoresis: correlation with plasmapheresis in light chain disease nephropathy. Am J Hematol 1983;15:75-88.
30. Brouwer J, Otting-van de Ruit M, Busking-van der Lely H. Estimation of free light chains of immunoglobulins by enzyme immunoassay. Clin Chim Acta 1985;150:267-74.
31. Rudick RA, Peter DR, Bidlack JM, Knutson DW. Multiple sclerosis: free light chains in cerebrospinal fluid. Neurology 1985;35:1443-9.
32. Teppo AM, Groop L. Urinary excretion of plasma proteins in diabetic subjects. Increased excretion of kappa light chains in diabetic patients with and without proliferative retinopathy. Diabetes 1985;34:589-94.
33. Axiak SM, Krishnamoorthy L, Guinan J, Raison RL. Quantitation of free κ light chains in serum and urine using a monoclonal antibody based inhibition enzyme-linked immunoassay. J Immunol Methods 1987;99:141-7.
34. Fagnart OC, Sindic CJ, Laterre C. Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J Neuroimmunol 1988;19:119-32.
35. Lolli F, Amaducci L. Measurement of free kappa immunoglobulin light chains in the cerebrospinal fluid by a competitive avidin-biotin ELISA. Clin Chim Acta 1989;182:229-34.
36. Mehta PD, Cook SD, Troiano RA, Coyle PK. Increased free light chains in the urine from patients with multiple sclerosis. Neurology 1991;41:540-4.
37. Stanescu GL, Swick AR, Tuohy VK, Rudick RA. Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluid. J Clin Lab Anal 1991;5:206-11.
38. Tillyer CR, Iqbal J, Raymond J, Gore M, McIlwain TJ. Immunoturbidimetric assay for estimating free light chains of immunoglobulins in urine and serum. J Clin Pathol 1991;44:466-71.
39. Wakasugi K, Sasaki M, Suzuki M, Azuma N, Nobuto T. Increased concentrations of free light chain lambda in sera from chronic hemodialysis patients. Biomater Artif Cells Immobilization Biotechnol 1991;19:97-109.
40. Nelson M, Brown RD, Gibson J, Joshua DE. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma. Br J Haematol 1992;81:223-30.
41. Wakasugi K, Suzuki H, Imai A, Konishi S, Kishioka H. Immunoglobulin free light chain assay using latex agglutination. Int J Clin Lab Res 1995;25:211-5.
42. Ohtani K, Mashiko T, Jimbo S, Ohtani H. Determination of free light chain in urine by latex immunoassay. Kitasato Med 1997;27:33-26.
43. Abe M, Goto T, Kosaka M, Wolfenbarger D, Weiss DT, Solomon A. Differences in kappa to lambda (κ:λ) ratios of serum and urinary free light chains. Clin Exp Immunol 1998;111:457-62.
44. Nakano T, Nagata A. ELISAs for free light chains of human immunoglobulins using monoclonal antibodies: comparison of their specificity with available polyclonal antibodies. J Immunol Methods 2003;275:9-17.
45. Epstein WV, Tan M. Increase of L-chain proteins in the sera of patients with systemic lupus erythematosus and the synovial fluids of patients with peripheral rheumatoid arthritis. Arthritis Rheum 1966;9:713-9.
46. Cooper A, Bluestone R. Free immunoglobulin light chains in connective tissue diseases. Ann Rheum Dis 1968;27:537-43.
47. Le Bricon T, Bengoufa D, Benlakehal M, Bousquet B, Erlich D. Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma. Clin Biochem 2002;35:565-7.
48. Levinson SS. Studies of Bence Jones proteins by immunonephelometry. Ann Clin Lab Sci 1992;22:100-9.
49. Boege F, Koehler B, Liebermann F. Identification and quantification of Bence-Jones proteinuria by automated nephelometric screening. J Clin Chem Clin Biochem 1990;28:37-42.
50. Nakano T, Nagata A, Takahashi H. Ratio of urinary free immunoglobulin light chain κ to λ in the diagnosis of Bence Jones proteinuria. Clin Chem Lab Med 2004;42:429-34.
51. Boux HA, Raison RL, Walker KZ, Hayden GE, Basten A. A tumor-associated antigen specific for human kappa myeloma cells. J Exp Med 1983;158:1769-74.
52. Abe M, Goto T, Kennel SJ, Wolfenbarger D, Macy SD, Weiss DT, et al. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies. Am J Clin Pathol 1993;100:67-74.
53. Jenkins MA, O'Leary TD, Guerin MD. Identification and quantitation of human urine proteins by capillary electrophoresis. J Chromatogr B Biomed Appl 1994;662:108-12.
54. Katzmann JA, Clark R, Sanders E, Landers JP, Kyle RA. Prospective study of serum protein capillary zone electrophoresis and immunotyping of monoclonal proteins by immunosubtraction. Am J Clin Pathol 1998;110:503-9.
55. Bradwell AR, Carr-Smith HD, Mead GP, Harvey TC, Drayson MT. Serum test for assessment of patients with Bence Jones myeloma. Lancet 2003;361:489-91.
56. Mead GP, Carr-Smith HD, Drayson MT, Bradwell AR. Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using immunoassays specific for free immunoglobulin light chains. Clin Lab 2003;49:25-7.
57. Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 2001;97:2900-2.
58. Graziani MS, Merlini G. Measurement of free light chains in urine. Clin Chem 2001;47:2069-70.
59. Heino J, Rajamaki A, Irjala K. Turbidimetric measurement of Bence-Jones proteins using antibodies against free light chains of immunoglobulins. An artifact caused by different polymeric forms of light chains. Scand J Clin Lab Invest 1984;44:173-6.
60. Sölling K. Polymeric forms of free light chains in serum from normal individuals and from patients with renal diseases. Scand J Clin Lab Invest 1976;36:447-52.
61. Nakano T, Miyazaki S, Shinoda Y, Inoue I, Katayama S, Komoda T, et al. A proposed reference material for human free immunoglobulin light chain measurement. J Immunoassay Immunochem. In press.
62. Carr-Smith H, Edwards J, Showell P, Drew R, Tang LX, Bradwell AR. Preparation of an immunoglobulin free light-chain reference material. Clin Chem 2000;46:A180.
63. Kyle RA. Sequence of testing for monoclonal gammopathies. Arch Pathol Lab Med 1999;123:114-8.
64. Keren DF, Alexanian R, Goeken JA, Gorevic PD, Kyle RA, Tomar RH. Guidelines for clinical and laboratory evaluation patients with monoclonal gammopathies. Arch Pathol Lab Med 1999;123:106-7.
65. Bush D, Keren DF. Over- and underestimation of monoclonal gammopathies by quantification of κ- and λ-containing immunoglobulins in serum. Clin Chem 1992;38:315-6.
66. Riches PG, Sheldon J, Smith AM, Hobbs JR. Overestimation of monoclonal immunoglobulin by immunochemical methods. Ann Clin Biochem 1991;28:253-9.
67. Smith AM, Thompson RA. Paraprotein estimation: a comparison of immunochemical and densitometric techniques. J Clin Pathol 1978;31:1156-60.
68. Hemmingsen L, Skaarup P. The 24-h excretion of plasma proteins in the urine of apparently healthy subjects. Scand J Clin Lab Invest 1975;35:347-53.
69. Groop L, Makipernaa A, Stenman S, DeFronzo RA, Teppo AM. Urinary excretion of kappa light chains in patients with diabetes mellitus. Kidney Int 1990;37:1120-5.
70. Ohtani S, Ohtani H. Clinical significance of free light chain in urine by latex agglutination immunoassay. Kitasato Med 1998;28:435-45.
71. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free κ and free λ immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48:1437-44.
72. Sölling K. Normal values for free light chains in serum different age groups. Scand J Clin Lab Invest 1977;37:21-5.
73. Waldmann TA, Strober W, Mogielnicki RP. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J Clin Invest 1972;51:2162-74.